Global $11.4 Billion Pancreatic Cancer Diagnostics Using Artificial Intelligence for Hospitals Market, 2023

DUBLIN, October 27, 2017 /PRNewswire/ --

The "Pancreatic Cancer Diagnostics Using Artificial Intelligence for Hospitals: Market Shares, Strategies, and Forecasts, Worldwide 2017 - 2023" report from Wintergreen Research, Inc has been added to Research and Markets' offering.

Hospital artificial intelligence market shipments at $1.7 billion in 2023 are forecast to reach $11.4 billion dollars, worldwide 2023

Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and lowering care delivery costs.

Automated cancer diagnostics are implemented with artificial intelligence. Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans. The analysis of patient records, looking for effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the artificial intelligence is being used to do that. Systems are making a significant difference in saving lives.

Much of the hospital artificial intelligence market is centered on improving diagnosis and treatment of cancer through the visualization provided by radiology. The systems are able to track and analyze more data, more accurately than can the humans. Radiologists receive years of training. They are among the highest paid doctors, also among the first group of physicians utilizing artificial intelligence because of the complexity of the task to be done.

Artificial Intelligence for Hospital Cancer Diagnostics Market Forecasts AI is set to become a sophisticated diagnostic aid, flagging images that humans should examine more closely, while leaving radiologists with more time for interacting with patients and medical staff.

Key Topics Covered:

1. Artificial Intelligence Cancer Diagnostics Market Description and Market Dynamics:
1.1 Artificial Intelligence Very Big Breakthrough in Cancer Diagnostics
1.2 Ability of AI Solutions To Discover Schemas in Large Databases

2. Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces
2.1 Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces
2.2 Artificial Intelligence Cancer Diagnostics Market Shares:
2.3 Artificial Intelligence for Cancer Diagnostics Market Forecasts:
2.4 Cancer Statistics
2.5 Hospital Artificial Intelligence (AI) Challenges
2.6 Hospital Artificial Intelligence Software Prices:
2.7 Hospital Artificial Intelligence Regional Segments:

3. Hospital Artificial Intelligence Products:
3.1 Partners HealthCare, IBM, and GE Healthcare
3.2 IBM Watson
3.3 Google's AI Subsidiary DeepMind is Partnering With Another UK hospital
3.4 Prognos

4. Hospital Artificial Intelligence Research and Technology:
4.1 Research at Google
4.2 IBM AI Research
4.3 Google and Nvidia Artificial Intelligence

5. Hospital Artificial Intelligence Companies
5.1 Alphabet / Google
5.2 General Electric (GE)
5.3 IBM
5.4 Prognos
5.5 Quest Diagnostics
5.6 Safeguard Scientifics Announces Second Quarter 2017 Financial Results

6. Research Methodology

Companies Mentioned

• Alphabet
• Atomwise
• BenevolentAI
• Berg
• Drug Discovery Artificial Intelligence
• Exscientia
• General Electric
• GlaxoSmithKline (GSK)
• Google
• IBM
• Merck
• Numerate
• Prognos
• Quest Diagnostics
• Safeguard Scientifics
• twoXAR
• Zebra

For more information about this report visit https://www.researchandmarkets.com/research/7bs28p/pancreatic_cancer

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com